Brent D. Butts

1.1k total citations
16 papers, 761 citations indexed

About

Brent D. Butts is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Brent D. Butts has authored 16 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Brent D. Butts's work include Cell death mechanisms and regulation (7 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Cancer-related Molecular Pathways (2 papers). Brent D. Butts is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Cancer-related Molecular Pathways (2 papers). Brent D. Butts collaborates with scholars based in United States, Japan and Canada. Brent D. Butts's co-authors include Daniel A. Linseman, Shoshona S. Le, Kim A. Heidenreich, Ron J. Bouchard, Tracey A. Laessig, Reid A. Phelps, Maria L. Florez‐McClure, Mehmet Haberal, Caroline Houde and Margaret M. Briehl and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Journal of Neurochemistry.

In The Last Decade

Brent D. Butts

16 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brent D. Butts United States	12	500	96	67	65	62	16	761
Jianhua Cao China	17	399 0.8×	93 1.0×	34 0.5×	115 1.8×	92 1.5×	52	785
Kenji Kameda Japan	17	293 0.6×	56 0.6×	51 0.8×	47 0.7×	95 1.5×	40	765
Pablo M. Peixoto United States	18	897 1.8×	99 1.0×	65 1.0×	137 2.1×	63 1.0×	29	1.4k
Oleksandr Ekshyyan United States	15	444 0.9×	82 0.9×	48 0.7×	59 0.9×	178 2.9×	25	883
Akiko Hayashi Japan	13	374 0.7×	80 0.8×	26 0.4×	42 0.6×	38 0.6×	38	726
Shiri Procaccia Israel	5	485 1.0×	54 0.6×	65 1.0×	66 1.0×	88 1.4×	5	810
Weiyun Li China	17	566 1.1×	95 1.0×	142 2.1×	40 0.6×	85 1.4×	31	1.2k
Liora Lindenboim Israel	17	677 1.4×	124 1.3×	114 1.7×	24 0.4×	84 1.4×	25	973
Matthew Nichols Canada	15	343 0.7×	70 0.7×	48 0.7×	54 0.8×	57 0.9×	33	640
Shaojun Liu China	17	467 0.9×	66 0.7×	66 1.0×	55 0.8×	51 0.8×	56	941

Countries citing papers authored by Brent D. Butts

Since Specialization

Citations

This map shows the geographic impact of Brent D. Butts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent D. Butts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent D. Butts more than expected).

Fields of papers citing papers by Brent D. Butts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent D. Butts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent D. Butts. The network helps show where Brent D. Butts may publish in the future.

Co-authorship network of co-authors of Brent D. Butts

This figure shows the co-authorship network connecting the top 25 collaborators of Brent D. Butts. A scholar is included among the top collaborators of Brent D. Butts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent D. Butts. Brent D. Butts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Iyer, Gopa, Hiromichi Ebi, Natalie Cook, et al.. (2025). A first-in-human phase 1 study of LY3866288 (LOXO-435), a potent, highly isoform-selective FGFR3 inhibitor (FGFR3i) in advanced solid tumors with FGFR3 alterations: Initial results from FORAGER-1.. Journal of Clinical Oncology. 43(5_suppl). 662–662. 4 indexed citations

Garon, Edward B., Martin Reck, Kazuto Nishio, et al.. (2023). Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results. ESMO Open. 8(4). 101580–101580. 11 indexed citations

Ackermann, Bradley L., Ryan D. Morrison, Matthew D Westfall, et al.. (2023). Targeted Quantitative Mass Spectrometry Analysis of Protein Biomarkers From Previously Stained Single Formalin-Fixed Paraffin-Embedded Tissue Sections. Laboratory Investigation. 103(4). 100052–100052. 3 indexed citations

Perets, Ruth, Kiyotaka Yoh, Dong‐Wan Kim, et al.. (2019). Antitumor activity and safety of MK-1308 (anti-CTLA-4) plus pembrolizumab (pembro) in patients (pts) with non-small cell lung cancer (NSCLC): Updated interim results from a phase I study.. Journal of Clinical Oncology. 37(15_suppl). 2558–2558. 1 indexed citations

Ai, Xi, et al.. (2011). Generation and characterization of antibodies specific for caspase-cleaved neo-epitopes: a novel approach. Cell Death and Disease. 2(9). e205–e205. 15 indexed citations

Butts, Brent D., Caroline Houde, & Mehmet Haberal. (2008). Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease. Cell Death and Differentiation. 15(7). 1178–1186. 99 indexed citations

Kropinski, Andrew M., Stephen J. Billington, Aaron Patrick, et al.. (2007). The genome of ε15, a serotype-converting, Group E1 Salmonella enterica-specific bacteriophage. Virology. 369(2). 234–244. 52 indexed citations

Phelps, Reid A., Daniel A. Linseman, Brent D. Butts, et al.. (2005). The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis. Cell Death and Differentiation. 12(3). 255–265. 72 indexed citations

Zimmermann, Angela, F. Alexandra Loucks, Shoshona S. Le, et al.. (2005). Distinct mechanisms of neuronal apoptosis are triggered by antagonism of Bcl‐2/Bcl‐x(L) versus induction of the BH3‐only protein Bim. Journal of Neurochemistry. 94(1). 22–36. 21 indexed citations

10.

Butts, Brent D., Daniel A. Linseman, Shoshona S. Le, et al.. (2005). Proteasome inhibition elicits a biphasic effect on neuronal apoptosis via differential regulation of pro-survival and pro-apoptotic transcription factors. Molecular and Cellular Neuroscience. 30(2). 279–289. 30 indexed citations

11.

Butts, Brent D., Nhan L. Tran, & Margaret M. Briehl. (2004). Identification of a functional peroxisome proliferator activated receptor response element in the 3' untranslated region of the human bcl-2 gene. International Journal of Oncology. 24(5). 1305–10. 17 indexed citations

12.

Linseman, Daniel A., Brent D. Butts, Reid A. Phelps, et al.. (2004). Glycogen Synthase Kinase-3β Phosphorylates Bax and Promotes Its Mitochondrial Localization during Neuronal Apoptosis. Journal of Neuroscience. 24(44). 9993–10002. 323 indexed citations

13.

Butts, Brent D., Kevin Kwei, G. Tim Bowden, & Margaret M. Briehl. (2003). Elevated basal reactive oxygen species and phospho‐Akt in murine keratinocytes resistant to ultraviolet B–induced apoptosis. Molecular Carcinogenesis. 37(3). 149–157. 16 indexed citations

14.

Butts, Brent D., Daniel A. Linseman, Shoshona S. Le, Tracey A. Laessig, & Kim A. Heidenreich. (2003). Insulin-like Growth Factor-I Suppresses Degradation of the Pro-survival Transcription Factor Myocyte Enhancer Factor 2D (MEF2D) During Neuronal Apoptosis. Hormone and Metabolic Research. 35(11/12). 763–770. 10 indexed citations

15.

Gupta, Ashok, Brent D. Butts, Kevin Kwei, et al.. (2001). Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression. Cancer Letters. 173(2). 115–125. 63 indexed citations

16.

Butts, Brent D., et al.. (2000). Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase.. PubMed. 60(13). 3638–44. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact